An essential tool for detection of respiratory illnesses

By performing just a single test healthcare personnel is now able to simultaneously detect eighteen of the most prevalent respiratory infections in patients. The Seeplex 18-plex Respiratory Test is a highly economical method for molecular diagnostics of respiratory infections. It achieves results rapidly at minimal costs per test.

Seegene invents its new Seeplex 18-plex Respiratory Test as an essential tool for active surveillance and treatment of respiratory illnesses. Compared to the usual ‘single pathogen – single test’ testing regime the new multiplex-formatted diagnostic test, for which nasopharyngeal spirates, nasopharyngeal swabs or bronchoalveolar lavage samples could be used, is cost-effective and delivers fast results.

The Test detects the following RNA viruses, DNA viruses and pneumonia bacteria:

      -     Influenza A virus
-          Influenza B virus
-          Human respiratory syncytial virus A
-          Human respiratory syncytial cirus B
-          Human parainfluenzae virus 1
-          Human parainfluenzae virus 2
-          Human parainfluenzae virus 3
-          Human coronavirus 229E/NL63
-          Human coronavirus OC43/HKU1
-          Human rhinovirus
-          Human enterovirus
-          Human adenovirus
-          Human bocavirus
-          Legionella pneumoniae
-          Streptococcus pneumoniae
-          Chlamydophila pneumoniae
-          Haemophilus influenzae
-        Mycoplasma pneumoniae

14.09.2007

News • NHS rollout

Liquid biopsy: new ‘blood test-first’ approach for lung cancer

A new ‘liquid biopsy’ test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping avoid further tests and treatments including chemotherapy.

Article • San Antonio Breast Cancer Symposium (SABCS)

Young women and breast cancer: research in focus

At the San Antonio Breast Cancer Symposium (SABCS), three experts presented new approaches and study results for the treatment of breast cancer in young women.

News • Combining spatial transcriptomics, pseudotime and machine learning

More precise than PSA: New biomarkers for prostate cancer found in urine

Using AI and extensive analyses of gene activity in tumours, researchers have found new, precise biomarkers to diagnose prostate cancer at an early stage through a simple urine sample.